Camber Capital Management’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $21.9M | Buy |
|
|||||
|
2024
Q4 | $21.9M | Buy |
|
|||||
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $43.8M | Sell |
|
|||||
|
2023
Q3 | $102M | Sell |
|
|||||
|
2023
Q2 | $103M | Buy |
|
|||||
|
2023
Q1 | $68.8M | Hold |
|
|||||
|
2022
Q4 | $72.7M | Hold |
|
|||||
|
2022
Q3 | $85.1M | Sell |
|
|||||
|
2022
Q2 | $100M | Sell |
|
|||||
|
2022
Q1 | $111M | Buy |
|
|||||
|
2021
Q4 | $42.3M | Sell |
|
|||||
|
2021
Q3 | $83.8M | Buy |
|
|||||
|
2021
Q2 | $79.8M | Buy |
|
|||||
|
2021
Q1 | $45M | Buy |
|